UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

The Evolving Field of Tyrosine Kinase Inhibitors in the Treatment of Endocrine Tumors

Endocrine reviews, 2010-08, Vol.31 (4), p.578-599

2010

Volltextzugriff (PDF)

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

Breast cancer research and treatment, 2012-07, Vol.134 (1), p.333-343

2012

Volltextzugriff (PDF)

Genetic alterations in the RAS/RAF/mitogen‐activated protein kinase and phosphatidylinositol 3‐kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma

Cancer, 2010-06, Vol.116 (12), p.2974-2983

2010

Volltextzugriff (PDF)

Prognostic and Therapeutic Implications of Distinct Kinase Expression Patterns in Different Subtypes of Breast Cancer

Cancer research (Chicago, Ill.), 2010-11, Vol.70 (21), p.8852-8862

2010

Volltextzugriff (PDF)

Missense Mutation in the Transcription Factor NKX2–5: A Novel Molecular Event in the Pathogenesis of Thyroid Dysgenesis

The journal of clinical endocrinology and metabolism, 2006-04, Vol.91 (4), p.1428-1433

2006

Volltextzugriff (PDF)

Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma

Human pathology, 2009-06, Vol.40 (6), p.827-833

2009

Volltextzugriff (PDF)

Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification

Human pathology, 2008, Vol.39 (1), p.15-20

2008

Volltextzugriff (PDF)

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

Cancer, 2012-05, Vol.118 (10), p.2603-2614

2012

Volltextzugriff (PDF)

Targeting triple negative breast cancer: Is p53 the answer?

Cancer treatment reviews, 2013-08, Vol.39 (5), p.541-550

2013

Volltextzugriff (PDF)

Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer

JNCI : Journal of the National Cancer Institute, 2011-02, Vol.103 (3), p.264-272

2011

Volltextzugriff (PDF)

Phosphatidylinositol 3-Kinase/Akt and Ras/Raf-Mitogen-Activated Protein Kinase Pathway Mutations in Anaplastic Thyroid Cancer

The journal of clinical endocrinology and metabolism, 2008-01, Vol.93 (1), p.278-284

2008

Volltextzugriff (PDF)

Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient with von Hippel-Lindau Disease: Targeting Angiogenic Factors in Pheochromocytoma and Other von Hippel-Lindau Disease-Related Tumors

The journal of clinical endocrinology and metabolism, 2009-02, Vol.94 (2), p.386-391

2009

Volltextzugriff (PDF)

High Resolution Array-Comparative Genomic Hybridization Profiling Reveals Deoxyribonucleic Acid Copy Number Alterations Associated with Medullary Thyroid Carcinoma

The journal of clinical endocrinology and metabolism, 2008-11, Vol.93 (11), p.4367-4372

2008

Volltextzugriff (PDF)

Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer

Head & neck, 2009-03, Vol.31 (3), p.419-423

2009

Volltextzugriff (PDF)

Predictive molecular markers of anthracycline effectiveness in early breast cancer: Moving Forward with New Data and Approaches: A Fresh Look at Anthracyclines in Breast Cancer. Summary of a workshop held in September 2010

European journal of cancer supplements, 2011, Vol.9 (2), p.16-21

2011

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)
Japanisch
(7)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The Evolving Field of Tyrosine Kinase Inhibitors in the Treatment of Endocrine Tumors

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

Genetic alterations in the RAS/RAF/mitogen‐activated protein kinase and phosphatidylinositol 3‐kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma

Prognostic and Therapeutic Implications of Distinct Kinase Expression Patterns in Different Subtypes of Breast Cancer

Missense Mutation in the Transcription Factor NKX2–5: A Novel Molecular Event in the Pathogenesis of Thyroid Dysgenesis

Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma

Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

Targeting triple negative breast cancer: Is p53 the answer?

Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer

Phosphatidylinositol 3-Kinase/Akt and Ras/Raf-Mitogen-Activated Protein Kinase Pathway Mutations in Anaplastic Thyroid Cancer

Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient with von Hippel-Lindau Disease: Targeting Angiogenic Factors in Pheochromocytoma and Other von Hippel-Lindau Disease-Related Tumors

High Resolution Array-Comparative Genomic Hybridization Profiling Reveals Deoxyribonucleic Acid Copy Number Alterations Associated with Medullary Thyroid Carcinoma

Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer

Predictive molecular markers of anthracycline effectiveness in early breast cancer: Moving Forward with New Data and Approaches: A Fresh Look at Anthracyclines in Breast Cancer. Summary of a workshop held in September 2010

Aktive Filter

Suchergebnisse filtern